Pura Vida Investments’s Amicus Therapeutics FOLD Stock Holding History

Pura Vida Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-196,800	Closed	-$1.88M	–	264
2021 Q3	$1.88M	Sell	196,800 -370,500	-65%	-$3.79M	0.06%	193
2021 Q2	$5.47M	Sell	567,300 -55,200	-9%	-$539K	0.17%	108
2021 Q1	$6.15M	Sell	622,500 -177,500	-22%	-$2.75M	0.18%	110
2020 Q4	$18.5M	Buy	800,000 +200,000	+33%	+$4.09M	0.67%	35
2020 Q3	$8.47M	Buy	+600,000	New	+$8.74M	0.44%	45
2018 Q3	–	Sell	-50,000	Closed	-$781K	–	116
2018 Q2	$781K	Buy	+50,000	New	+$756K	0.31%	74
2017 Q4	–	Sell	-200,000	Closed	-$3.02M	–	82
2017 Q3	$3.02M	Buy	+200,000	New	+$2.65M	0.88%	45
2016 Q2	–	Sell	-100,000	Closed	-$845K	–	83
2016 Q1	$845K	Buy	+100,000	New	+$708K	0.38%	59

Other funds holding FOLD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pura Vida Investments's FOLD Position: Q2 2021 in Review

Pura Vida Investments sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 45,525 shares — an estimated $444K sold.

Pura Vida Investments first reported a position in FOLD in Q1 2018 and held it in 6 quarters. The position peaked at $2.23M in Q3 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

Pura Vida Investments reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
Pura Vida Investments sold 45,525 Amicus Therapeutics shares in Q2 2021, an estimated $444K.
Pura Vida Investments first reported a position in Amicus Therapeutics in Q1 2018 and held it in 6 quarters.
Pura Vida Investments's Amicus Therapeutics position peaked at $2.23M in Q3 2020.
235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.